Media & Resources

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible

A series of publications highlights advancements in countermeasures for Lassa fever, an animal-borne illness

In this episode of Meet the Scientist, we explore IAVI’s efforts in the late-stage development of the MTBVAC TB vaccine candidate

Research literacy learning collaborative led by CASPR brings together health advocates in Africa, linking the science of vaccine development to vaccine advocacy.

IAVI is honored to be co-organizing the 7th Global Forum on TB Vaccines at a time of heightened attention to TB vaccine development and implementation.

New publications in Nature Immunology show primed B cells in mice and non-human primates and germline-targeting immunogens could drive MPER-specific precursors toward bnAbs